Page 3 - Graphite Bio News Today

Pluri (NASDAQ:PLUR – Get Free Report) and Graphite Bio (NASDAQ:GRPH – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation. Analyst Ratings This is a breakdown of recent […]

BioPharma

BioPharma

-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 -- Pacira BioSciences, Inc. , the industry leader in its commitment...

Graphite Bio, Inc. (NASDAQ:GRPH – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totalling 1,060,000 shares, an increase of 7.0% from the August 15th total of 990,500 shares. Based on an average trading volume of 151,300 shares, the days-to-cover ratio […]

Graphite Bio (NASDAQ:GRPH – Get Free Report) and Talaris Therapeutics (NASDAQ:TALS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Analyst Ratings This is a breakdown of […]

Biogen Inc. said Wednesday it has appointed Dr. Jane Grogan as head of research, effective Oct. 2. Grogan was most recently chief scientific officer at...

CAMBRIDGE, Mass., Sept. 06, 2023 -- Biogen Inc. announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member...

By Colin Kellaher Biogen has tapped industry veteran Jane Grogan as executive vice president and head of research of the biotechnology company. Biogen on...

BioPharma